Cambium Oncology
Company Details
Status: Private
Employees: 11-50
Location:
Atlanta, Georgia, United States
Type:
sample
Technology:
sample
About: Cambium Oncology is a team of scientists, drug development experts, cancer physicians, and business leaders united in a shared vision of treating cancer with a novel immunotherapeutic that targets the VIP signaling pathway. Emory investigators discovered that small molecule antagonists to the VIP receptor on T cells could augment T cell-mediated immune responses to cancer, viral infections, and vaccines.
Cambium scientists developed and patented more potent molecules with longer half-lives that induce potent anti-cancer immune responses to leukemia and pancreatic cancer. Cambium Oncology is poised to transform the immuno-oncology field, with a first-in-class therapeutic against a novel immune checkpoint pathway.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Cambium Oncology | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.